- Home
- BSX
as 08-27-2025 9:37am EST
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
| Founded: | 1979 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 152.7B | IPO Year: | 1992 |
| Target Price: | $118.32 | AVG Volume (30 days): | 6.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 22 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.68 | EPS Growth: | 36.90 |
| 52 Week Low/High: | $78.90 - $108.94 | Next Earning Date: | 10-22-2025 |
| Revenue: | $18,494,000,000 | Revenue Growth: | 21.44% |
| Revenue Growth (this year): | 19.75% | Revenue Growth (next year): | 10.98% |
Stock Insider Trading Activity of Boston Scientific Corporation (BSX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fitzgerald Joseph Michael | BSX | EVP & Group Pres, Cardiology | Jun 4 '25 | Sell | $102.88 | 56,372 | $5,799,630.28 | 178,342 | |
| Mahoney Michael F | BSX | Chairman, President & CEO | Jun 2 '25 | Sell | $103.72 | 164,443 | $17,051,135.67 | 1,566,803 | |
| LUDWIG EDWARD J | BSX | Director | May 29 '25 | Sell | $104.59 | 4,000 | $418,367.60 | 22,479 |
Latest Boston Scientific Corporation News
BSX Breaking Stock News: Dive into BSX Ticker-Specific Updates for Smart Investing
Zacks
2 hours ago
Should You Add IDEXX Stock to Your Portfolio Right Now?
Zacks
2 hours ago
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
PR Newswire
6 hours ago
REALIZE Demo Day to Spotlight Health Tech Startups with Expert Insights and Investor Feedback
Zacks
a day ago
Is it the Right Time to Hold Labcorp Stock in Your Portfolio?
Zacks
2 days ago
Natera Shares Rise on the Launch of AI Platform for Precision Oncology
Zacks
2 days ago
IDEXX Gains 56.2% in a Year: What's Driving the Rally?
Zacks
2 days ago
HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?
MedTech Dive
2 days ago
Boston Scientific recalls carotid stents over manufacturing defect
Compare BSX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BSX Boston Scientific Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.